![Ming De Yu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ming De Yu
Chairman at Chinese Pharmaceutical Enterprises Association
Ming De Yu active positions
Companies | Position | Start | End |
---|---|---|---|
Chinese Pharmaceutical Enterprises Association | Chairman | 31/12/2003 | - |
China Medical Entrepreneur Association | Chairman | - | - |
Career history of Ming De Yu
Former positions of Ming De Yu
Companies | Position | Start | End |
---|---|---|---|
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Director/Board Member | 24/04/2012 | 05/01/2016 |
Independent Dir/Board Member | 24/04/2012 | 05/01/2016 | |
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Director/Board Member | 22/11/2009 | 31/12/2012 |
Independent Dir/Board Member | 31/07/2008 | 31/12/2012 | |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Director/Board Member | 20/05/2010 | 31/12/2011 |
Independent Dir/Board Member | 20/10/2011 | 31/12/2011 | |
Fuxin Traditional Chinese Medicine Co. | Chief Tech/Sci/R&D Officer | 31/12/1982 | 31/12/1982 |
Liaoning Fuxin Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | 31/12/1982 | 31/12/1982 |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Director/Board Member | - | - |
Beijing Pharmaceutical Group Co., Ltd.
![]() Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Director/Board Member | 12/12/2010 | - |
Chairman | 15/03/2010 | 12/12/2010 | |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Ming De Yu
Dalian University of Technology | Undergraduate Degree |
Statistics
International
China | 12 |
Operational
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Chairman | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
3SBIO INC. | Health Technology |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Health Technology |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Health Technology |
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 6 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
![]() China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Pharmaceutical Group Co., Ltd.
![]() Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Health Technology |
Chinese Pharmaceutical Enterprises Association | |
China Medical Entrepreneur Association | |
Liaoning Fuxin Pharmaceutical Co. | |
Fuxin Traditional Chinese Medicine Co. |
- Stock Market
- Insiders
- Ming De Yu
- Experience